Did we overcome rheumatic heart disease or is it still a public disease burden?
Rheumatic heart disease (RHD), affecting approximately 32 million people all over the world is one of the major causes of cardiovascular morbidity and mortality especially in developing countries. In this ongoing pilot study, we aim to investigate the prevalence of both definitive and borderline RHD...
Main Authors: | Erkan Yildirim, Baris Bugan |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Turaz Bilim
2018-03-01
|
Series: | Medicine Science |
Subjects: | |
Online Access: | http://www.ejmanager.com/fulltextpdf.php?mno=281563 |
Similar Items
-
Rheumatic Heart Disease Is a Neglected Disease Relative to Its Burden Worldwide: Findings From Global Burden of Disease 2019
by: Seyyed‐Hadi Ghamari, et al.
Published: (2022-07-01) -
Rheumatic fever and rheumatic heart disease: Where are we now in South Africa?
by: Mark E. Engel, et al.
Published: (2017-04-01) -
Recent Advances in the Rheumatic Fever and Rheumatic Heart Disease Continuum
by: Joselyn Rwebembera, et al.
Published: (2022-01-01) -
Global research priorities in rheumatic fever and rheumatic heart disease
by: Carapetis Jonathan, et al.
Published: (2011-01-01) -
"SURVEY OF PREVALENCE RATE OF RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE AMONG SCHOOL CHILDREN IN TEHRAN"
by: M. Nadimi., et al.
Published: (1973-06-01)